Abstract:Patients with chronic immune-mediated arthritis exhibit abnormal hypothalamo-pituitary-adrenal (HPA) axis activity. The basis for this abnormality is not known. Immune-mediated arthritis is associated with increased extra-adrenal synthesis of active glucocorticoids by the 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme. 11β-HSD1 is expressed in the central nervous system, including regions involved in HPA axis regulation. We examined whether altered 11β-HSD1 expression within these regions contributes to HPA axis dysregulation during arthritis. The expression of 11β-HSD1, and other components of glucocorticoid signaling, were examined in various brain regions and the pituitary gland of mice with experimentally induced arthritis. Two arthritis protocols were employed: The K/BxN spontaneous arthritis model for chronic arthritis and the K/BxN serum transfer arthritis model for acute arthritis. 11β-HSD1 mRNA (Hsd11b1) was expressed in the hippocampus, hypothalamus, cortex, cerebellum and pituitary gland. Hypothalamic Hsd11b1 expression did not change in response to arthritis in either model. Pituitary Hsd11b1 expression was however significantly increased in both chronic and acute arthritis models. Hippocampal Hsd11b1 was decreased in acute but not chronic arthritis. Chronic, but not acute, arthritis was associated with a reduction in hypothalamic corticotropin-releasing hormone and arginine vasopressin expression. In both models, serum adrenocorticotropic hormone and corticosterone levels were no different from non-inflammatory controls. These findings demonstrate inflammation-dependent regulation of Hsd11b1 expression in the pituitary gland and hippocampus. The upregulation of 11β-HSD1 expression in the pituitary during both chronic and acute arthritis, and thus, an increase in glucocorticoid negative feedback, could contribute to the abnormalities in HPA axis activity seen in immune-mediated arthritis.

Interleukin-1-Beta - A Putative Mediator of Hpa Axis Hyperactivity in Major Depression

Linking peripheral IL-6, IL-1 and hypocretin-1 with cognitive impairment from major depression

Relationships Between Interleukin-6 Activity, Acute Phase Proteins, and Function of the Hypothalamic-Pituitary-adrenal Axis in Severe Depression.

Increased Serum Interleukin-1-receptor-antagonist Concentrations in Major Depression

Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.

Increased Plasma Levels of IL-6 Are Associated with Striatal Structural Atrophy in Major Depressive Disorder Patients with Anhedonia

Immunoendocrine Aspects of Major Depression

Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression.

A Further Exploration of the Relationships Between Immune Parameters and the Hpa-Axis Activity in Depressed-Patients

Multiple Reciprocal Relationships Betweenin Vivocellular Immunity and Hypothalamic–pituitary–adrenal Axis in Depression

Increased Serum IL-6 and IL-1 Receptor Antagonist Concentrations in Major Depression and Treatment Resistant Depression.

Depression‐related Disturbances in Mitogen‐induced Lymphocyte Responses and Interleukin‐1β and Soluble Interleukin‐2 Receptor Production

Immune Disturbances During Major Depression: Upregulated Expression of Interleukin-2 Receptors

Impaired Lymphocyte Stimulation by Mitogens in Severely Depressed Patients

Plasma Levels of Interleukin-6, Interleukin-10, and Interleukin-1 Receptor Antagonist in Depression: Comparison Between the Acute State and after Remission

Activation of the interleukin-23/Th17 axis in major depression: a systematic review and meta-analysis

Indicators of Immune Activation in Major Depression.

Role of 11Β-Hsd Type 1 in Abnormal HPA Axis Activity During Immune-Mediated Arthritis.

Some Interleukins, Their Receptors and Alpha-1-Acid Glycoprotein As the Indicators of Immune Activation in Major Depression

Increased Neopterin and Interferon-Gamma Secretion and Lower Availability of L-tryptophan in Major Depression: Further Evidence for an Immune Response

Depression, Traumatic Stress and Interleukin-6